Table 2.
Univariate Variable | Comparison | Estimated Coefficient (SEM) | Unadjusted Rate Ratio (95% CI) | P Value |
Age per 1 yr | 0.01 (0.002) | 1.01 (1.007 to 1.013) | 0.0001 | |
Sex | Female versus male | 0.46 (0.03) | 1.581 (1.481 to 1.688) | 0.0001 |
Race | Asian versus white | −0.27 (0.05) | 0.762 (0.687 to 0.846) | 0.0001 |
Black versus white | 0.22 (0.04) | 1.241 (1.14 to 1.35) | 0.0001 | |
Ethnicity | Hispanic versus not Hispanic | −22.19 (79.0) | Extremely small | 0.99 |
Body mass index per one unit (kg/m2) | −0.04 (0.003) | 0.963 (0.957 to 0.969) | 0.0001 | |
Years of kidney diseases (per yr) | −0.09 (0.004) | 0.917 (0.909 to 0.925) | 0.0001 | |
Fasting blood glucose (per mg/dl) | −0.01 (0.0003) | 0.989 (0.988 to 0.99) | 0.0001 | |
Serum creatinine (per mg/dl) | 0.07 (0.008) | 1.075 (1.058 to 1.092) | 0.0001 | |
Serum albumin (per g/L) | 0.006 (0.001) | 1.006 (1.005 to 1.008) | 0.0001 | |
eGFR (per ml/min) | −0.008 (0.001) | 0.993 (0.99 to 0.995) | 0.0001 | |
Hemoglobin (per g/dl) | −0.22 (0.006) | 0.805 (0.796 to 0.815) | 0.0001 | |
HbA1c (per 1%) | −0.38 (0.01) | 0.687 (0.669 to 0.706) | 0.0001 | |
Serum fructosamine, µmol/L | −0.004 (0.003) | 0.996 (0.995 to 0.997) | 0.0001 | |
Average blood glucose (per 1 mg/dl) | −0.02 (0.006) | 0.977 (0.975 to 0.978) | 0.0001 | |
CAD | Yes versus no | 0.21 (0.03) | 1.231 (1.154 to 1.312) | 0.0001 |
CHF | Yes versus no | 0.44 (0.03) | 1.552 (1.455 to 1.655) | 0.0001 |
Hypertension | Yes versus no | 0.88 (0.12) | 2.409 (1.912 to 3.039) | 0.0001 |
Stroke history | Yes versus no | 0.16 (0.04) | 1.177 (1.096 to 1.264) | 0.0001 |
History of malignancy | Yes versus no | 0.43 (0.05) | 1.531 (1.386 to 1.692) | 0.0001 |
Medications | ||||
Sulfonylureas | Yes versus no | 0.15 (0.03) | 1.157 (1.082 to 1.237) | 0.0001 |
Any insulin | Yes versus no | 0.67 (0.04) | 1.949 (1.821 to 2.087) | 0.0001 |
Insulin with SU | Yes versus no | 1.18 (0.04) | 3.267 (3.048 to 3.508) | 0.0001 |
Oral other than SU | Yes versus no | −0.06 (0.03) | 0.945 (0.887 to 1.008) | 0.08 |
Outcome variable: number of >15 min events with glucose <60 mg/dl; n=80. HbA1c, hemoglobin A1c; CAD, coronary artery disease; CHF, congestive heart failure; SU, sulfonylureas.